Author

Frank V. Celeste

Observed names: F. Celeste, Frank Celeste

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), National Institutes of Health, National Human Genome Research Institute, National Center for Advancing Translational Sciences, Stony Brook University

ORCID: 0000-0002-4796-2026

Observed ORCID: 0000-0002-4796-2026

OpenAlex ID: A5050873463

Mutation Update forGNEGene Variants Associated with GNE Myopathy

2014 · Frank V. Celeste, Thierry Vilboux, et al. · Human Mutation · 112

Safety, pharmacokinetics and sialic acid production after oral administration of N -acetylmannosamine (ManNAc) to subjects with GNE myopathy

2017 · Xin Xu, Amy Q. Wang, et al. · Molecular Genetics and Metabolism · 67

Sialylation of Thomsen–Friedenreich Antigen is a Noninvasive Blood-Based Biomarker for GNE Myopathy

2014 · Petcharat Leoyklang, May Christine Malicdan, et al. · Biomarkers in Medicine · 23

Immunoglobulins in Human Serum Reactive with Murine Friend Leukaemia Virus

1980 · M. Bendinelli, A. Toniolo, et al. · Journal of General Virology · 8

Induction of Multiple Alternative Mitogenic Signaling Pathways Accompanies the Emergence of Drug-Tolerant Cancer Cells

2024 · Frank V. Celeste, Scott Powers · Cancers · 5

Advancing Pyrogen Testing for Vaccines with Inherent Pyrogenicity: Development of a Novel Reporter Cell-Based Monocyte Activation Test (MAT)

2025 · Sijia Yi, Jenny Xu, et al. · Vaccines · 2

Genetic Analysis Reveals that GNE Myopathy is an Underdiagnosed Neuromuscular Disorder (P2.044)

2015 · Marjan Huizing, May Christine Malicdan, et al. · Neurology · 2

2014 · M.C. Malicdan, L. Mian, et al. · Neuromuscular Disorders · 1

ManNAc Is Safe and Increases Sialic Acid Production in GNE Myopathy (P7.061)

2015 · Bradley Class, Frank Celeste, et al. · Neurology

Works count: 9

Citation count: 220

H-index: 5

I10-index: 3